Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.
Status:
Completed
Trial end date:
2018-10-23
Target enrollment:
Participant gender:
Summary
Clinical trial of "line extension" of drug ARAFARMADOL® 0.075% cream in a new formulation in
topical solution applicable in roll-on and with the same therapeutic indications approved for
the cream.